MedCap AB (publ)
STO:MCAP

Watchlist Manager
MedCap AB (publ) Logo
MedCap AB (publ)
STO:MCAP
Watchlist
Price: 563 SEK 3.68% Market Closed
Market Cap: 8.3B SEK
Have any thoughts about
MedCap AB (publ)?
Write Note

MedCap AB (publ)
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

MedCap AB (publ)
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
MedCap AB (publ)
STO:MCAP
Revenue
kr1.8B
CAGR 3-Years
26%
CAGR 5-Years
20%
CAGR 10-Years
7%
AddLife AB
STO:ALIF B
Revenue
kr9.7B
CAGR 3-Years
22%
CAGR 5-Years
31%
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Revenue
kr2.2B
CAGR 3-Years
76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Biotage AB
STO:BIOT
Revenue
kr2.1B
CAGR 3-Years
21%
CAGR 5-Years
15%
CAGR 10-Years
16%
G
Genovis AB
STO:GENO
Revenue
kr127m
CAGR 3-Years
22%
CAGR 5-Years
24%
CAGR 10-Years
30%
M
Magle Chemoswed Holding AB
STO:MAGLE
Revenue
kr170.4m
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
N/A
No Stocks Found

MedCap AB (publ)
Glance View

Market Cap
8.3B SEK
Industry
Life Sciences Tools & Services

MedCap AB is an investment company engaged in biotechnology and medical technology capital investments. The company is headquartered in Solna, Stockholm. The company went IPO on 2006-07-04. The firm reports four segments: Abilia, Unimedic, Quickels and Inpac. The Company’s portfolio includes such companies as Abilia AB, which is engaged in the development and marketing of aids within the fields of communication, cognition, noise and environmental control; Unimedic AB, engaged in contract manufacturing of liquid pharmaceuticals; Quickels Systems AB, which is engaged in the development and marketing of intensive medical care equipment, such as care bags and electrocardiogram (ECG) equipment; AirContainer Package System AB that offers a wide range of packaging solutions for the pharmaceutical industry, and Dunmedic AB, which offers medical products, medicines and food supplements.

MCAP Intrinsic Value
423.54 SEK
Overvaluation 25%
Intrinsic Value
Price

See Also

What is MedCap AB (publ)'s Revenue?
Revenue
1.8B SEK

Based on the financial report for Sep 30, 2024, MedCap AB (publ)'s Revenue amounts to 1.8B SEK.

What is MedCap AB (publ)'s Revenue growth rate?
Revenue CAGR 10Y
7%

Over the last year, the Revenue growth was 23%. The average annual Revenue growth rates for MedCap AB (publ) have been 26% over the past three years , 20% over the past five years , and 7% over the past ten years .

Back to Top